Follow the Gland Pharma Limited share price and the full directors' dealings record of the company, a listed issuer based in India. Shares are quoted on the IN market, under the oversight of SEBI (PIT + SAST). Operating in the Health Care sector, Gland Pharma Limited has logged 467 insider filings. Market capitalisation: €409.5bn. The latest transaction was disclosed on 9 February 2026 (Sale). Among the most active insiders: K. RAGHURAMACHANDRA RAO. Every trade is free.
467
Insider Decl.
n/a
Thresholds
€4m
78 ops.
Buy Volume
€232m
389 ops.
Sell Volume
Analyst consensus: bullish or bearish?
Analysts rate Gland Pharma Limited Buy (bullish), based on 14 analysts. Average price target: ₹2,286.00.
10Σ signal
Buys €4m€232m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 11,236 of 29,063 companies
57.2
score / 100
Value
35
Quality
79
FCF yld1.1%
Earn yld2.1%
EV/EBITDA25.7x
ROE11%
Gross mgn65%
Net mgn16%
Debt/EBITDA0.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
13,500 shares@ ₹542.006.0% of flowEquity SharesSEBI:a20dc8534285d6623e46638a10a13b5765a0c8dc
25 of 467 declarations
About Gland Pharma Limited
Gland Pharma Limited is an Indian pharmaceutical company specializing in the manufacture of injectable products. It is listed on the Bombay Stock Exchange.